Teladoc Health, Inc. (TDOC) - Q2 2025 10-Q Summary
Business Context and Reporting Period
This summary covers the quarterly period ended June 30, 2025. Teladoc Health operates two primary segments: Integrated Care (virtual medical services, chronic care management) and BetterHelp (virtual therapy and wellness). The company reported a net loss for the quarter but demonstrated improved profitability metrics compared to the prior year, driven by cost reductions and the absence of a massive goodwill impairment charge recorded in Q2 2024.
Key Financial Metrics
| Metric | Q2 2025 | Q2 2024 | YTD 2025 | YTD 2024 |
|---|---|---|---|---|
| Revenue | $631.9M | $642.4M | $1,261.3M | $1,288.6M |
| Net Loss | $(32.7M) | $(837.7M) | $(125.7M) | $(919.6M) |
| Adjusted EBITDA | $69.3M | $89.5M | $127.4M | $152.6M |
| Operating Cash Flow (YTD) | $107.4M (vs. $97.6M YTD 2024) | |||
| Free Cash Flow (YTD) | $45.5M (vs. $34.3M YTD 2024) | |||
| Cash & Equivalents | $679.6M (as of June 30, 2025) | |||
| Debt Outstanding | $1.0B (2027 Convertible Notes only) |
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased 2% year-over-year (Q2) and 2% year-over-year (YTD). The decline was driven by a 9% drop in BetterHelp revenue, partially offset by a 4% increase in Integrated Care revenue.
- Significant Loss Reduction: Net loss improved dramatically from $(837.7M) in Q2 2024 to $(32.7M) in Q2 2025. The prior year loss included a one-time $790 million goodwill impairment charge related to the Livongo acquisition, which is absent in the current period.
- Debt Repayment: The company repaid $550.6 million in convertible senior notes (Livongo Notes and 2025 Notes) during the first half of 2025. Only the $1.0 billion 2027 Notes remain outstanding.
- Acquisitions: Teladoc acquired Catapult Health (Integrated Care) and Uplift Health Technologies (BetterHelp) in early 2025. A $59.1 million goodwill impairment was recorded in Q1 2025 related to the Catapult Health acquisition.
- Cost Management: Operating expenses decreased significantly due to lower employee compensation, reduced marketing spend, and lower stock-based compensation ($22.3M in Q2 2025 vs. $42.1M in Q2 2024).
Outlook, Risks, and Unusual Items
- Segment Performance:
- Integrated Care: Revenue grew 4% QoQ and YoQ. U.S. members increased 11% to 102.4 million, though average monthly revenue per member declined to $1.27.
- BetterHelp: Revenue declined 9% YoY due to a 5% decrease in paying users. Adjusted EBITDA margin compressed to 4.9% from 9.6% in the prior year.
- Liquidity: The company maintains $679.6M in cash. On July 17, 2025 (subsequent event), Teladoc secured a new $300 million five-year revolving credit facility to enhance financial flexibility.
- Legal Proceedings: Multiple securities class actions and shareholder derivative suits remain pending, including matters related to BetterHelp's FTC consent order and alleged misrepresentations regarding advertising spend. Management does not currently expect a material adverse impact.
- Tax Impact: A discrete tax benefit of $20.1 million was recorded in Q1 2025 related to a research and development tax credit study, improving the effective tax rate for the period.
Investor Verification Checklist
- Revenue Mix: Verify the sustainability of the 11% growth in Integrated Care members against the declining revenue per member trend.
- BetterHelp User Trends: Confirm the drivers behind the 5% decline in BetterHelp paying users and the effectiveness of reduced marketing spend.
- Goodwill Impairment Risk: Assess the risk of future goodwill impairments in the Integrated Care segment, given the recent $59.1M charge and the note stating the reporting unit's carrying value exceeds fair value.
- Debt Maturity: Review the terms of the remaining $1.0B 2027 Convertible Notes and the impact of the new $300M credit facility on leverage ratios.
- Legal Exposure: Monitor the status of the consolidated securities litigation and BetterHelp-related class actions for potential settlement costs.